Growing Production Capacity Unolab is planning to increase its manufacturing capacity to 550 million doses in 2024, presenting opportunities to collaborate on supply chain scaling, raw material procurement, and process optimization for both existing and new clients.

Innovative Technology Adoption Utilizing advanced filling technology like Bottelpack positions Unolab as a capable partner for clients seeking high-quality, flexible sterile production solutions, especially in ophthalmic and respiratory areas, which could be targeted for technology-driven product development collaborations.

Strong International Presence Exportation to over 50 countries indicates a well-established distribution network and compliance infrastructure, providing a gateway for suppliers or service providers aiming to expand in global markets.

Sustainability and Quality Focus Unolab’s emphasis on product quality and innovation in sterile formulas aligns with growing demand in pharmaceuticals for reliable and compliant manufacturing partnerships, suitable for suppliers of high-grade raw materials or quality assurance services.

Mid-Sized Market Position With a revenue range of one to ten million dollars and around 150 employees, Unolab presents a dynamic customer profile for bespoke manufacturing solutions, technical equipment upgrades, and professional consulting tailored to mid-sized pharmaceutical CDMOs.